Market Overview

INTERMUNE SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Action Against InterMune, Inc. in Connection With Sale of Company to Roche Holding AG -- ITMN

Share:

NEW YORK, Sept. 3, 2014 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong notifies investors of claims of breaches of fiduciary duty against the Board of Directors of InterMune, Inc. (Nasdaq: ITMN) ("InterMune") in connection with the sale of the Company to Roche Holding AG. A complaint was filed in California state court.

Click here to learn about the case: http://docs.wongesq.com/ITMN-Info-Request-Form-370. There is no cost or obligation to you.

Under the terms of the transaction, InterMune shareholders will receive approximately $74 per share in cash for each share of InterMune stock they own. The claims concern whether the Board of InterMune breached their fiduciary duty to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Roche is underpaying for InterMune shares.

If you own common stock in InterMune and wish to obtain additional information, please contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/ITMN-Info-Request-Form-370.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: vw@wongesq.com
View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com